DXS International PLC (AQU:DXSP)
London · Delayed Price · Currency is GBP · Price in GBX 1.200
+0.050 (4.35%)
At close: Nov 11, 2025
DXS International Revenue
In the fiscal year ending April 30, 2025, DXS International had annual revenue of 3.47M GBP with 4.88% growth. DXS International had revenue of 1.74M in the half year ending April 30, 2025, with 0.02% growth.
Revenue
3.47M
Revenue Growth
+4.88%
P/S Ratio
0.22
Revenue / Employee
56.88K
Employees
61
Market Cap
768.27K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 3.47M | 161.56K | 4.88% |
| Apr 30, 2024 | 3.31M | -82.86K | -2.44% |
| Apr 30, 2023 | 3.39M | 106.17K | 3.23% |
| Apr 30, 2022 | 3.29M | -320.72K | -8.89% |
| Apr 30, 2021 | 3.61M | 325.98K | 9.94% |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |